Rulin Deniz

Dr. Rulin Deniz

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2026 in Hippocrates Medical Journal
Verified
Journal Article
Closed access
ATAlihan Tığlı
Alihan Tığlı
YBYakup Baykus
Yakup Baykus
RDRulin Deniz
Rulin Deniz
SÜSEFER ÜSTEBAY
SEFER ÜSTEBAY
MBMuammer Hayri Bektaş
Muammer Hayri Bektaş
ÇÇÇağdaş Çöllüoğlu
Çağdaş Çöllüoğlu
BackgroundThe use of generative large language models (LLMs) in healthcare is rapidly increasing, offering easier access to medical information. However, comprehensive data on their multilingual accuracy and the reliability of cited scientific references remain limited. This study aimed to compare the response accuracy and reference quality of three free LLMs (ChatGPT, Google Gemini, DeepSeek) in Turkish and English using common pregnancy-related questions.MethodsIn this comparative observational study, 14 frequently asked pregnancy questions were posed to each LLM in Turkish and English, requesting responses supported by up-to-date scientific web sources. Answers were evaluated blindly by obstetricians and gynaecologists for accuracy. References were independently assessed for reliability, scientific validity, and accessibility. Statistical analyses were performed.ResultsLanguage and model infrastructure significantly influenced performance. Google Gemini and DeepSeek provided more accurate responses in English than in Turkish (p

19 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
ATAlihan Tığlı
Alihan Tığlı
RDRulin Deniz
Rulin Deniz
TTToros Taskin
Toros Taskin
GAGüzide Ece Akinci
Güzide Ece Akinci
SASultan Deniz Altındağ
Sultan Deniz Altındağ
YBYakup Baykus
Yakup Baykus
Background/Objectives: This study aimed to evaluate the association between the clinical parameters of vaginal infection—specifically the presence, type, number of concurrent symptoms, and recurrence frequency—and cervical cytology findings, including inflammation severity, Candida, bacterial vaginosis, cellular abnormalities, and Human Papillomavirus (HPV) positivity. Methods: This prospective, cross-sectional, observational study included 458 women attending our gynecology outpatient clinic for Pap smear screening. Vaginal symptoms were documented through face-to-face interviews using a structured data collection form. Cervical samples were evaluated via liquid-based cytology by a single, experienced cytopathologist, who was blinded to the clinical data; cellular abnormalities, the degree of inflammation and cytomorphological findings indicative of infection were reported. HPV analysis was performed on the 218 women for whom results were available. Chi-square and trend chi-square tests were used in the statistical analysis. Results: No significant association was found between the clinical parameters of vaginal symptoms—specifically presence, concurrency, and recurrence frequency—and cytological abnormalities, HPV positivity and bacterial vaginosis (p > 0.05). In contrast, the prevalence of moderate-to-severe inflammation was significantly higher in women with vaginal discharge and a greater symptom burden (p < 0.05). Pruritus, dysuria, and vaginal burning were significantly associated with Candida positivity (p < 0.05). However, no significant association was found between the severity of cervical inflammation and abnormal cytology or HPV positivity (p > 0.05). In multivariable logistic regression analyses, neither symptom burden nor cervical inflammation severity was independently associated with abnormal cytology or HPV positivity. Conclusions: Our findings indicate that vaginal symptoms and the severity of cervical inflammation may not serve as definitive or independent discriminatory markers for cellular abnormalities or HPV positivity in this context. Nevertheless, specific symptom patterns may assist clinicians in evaluating localized infectious processes. Consequently, while standard cytological and molecular protocols remain essential for oncogenic screening, evaluating the overall symptom burden provides clinicians with a valuable framework for identifying benign dysbiotic and inflammatory processes. These findings remained consistent after adjustment for major clinical confounders.

18 June 2026 in Postgraduate Medicine
Verified
Journal Article
Closed access
RARamazan Mert Atan
Ramazan Mert Atan
ATAlihan Tığlı
Alihan Tığlı
KSKevser TARI SELÇUK
Kevser TARI SELÇUK
YBYakup Baykus
Yakup Baykus
RDRulin Deniz
Rulin Deniz
Dietary habits are increasingly recognized as an important modifiable risk factor in the management and prevention of polyendocrine metabolic ovarian syndrome (PMOS). However, evidence regarding the relationship between the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and PMOS is limited. The aim of this study is to investigate the relationship between the MIND diet score and PMOS, as well as its various phenotypes. This case-control study was conducted on 367 women (161 cases, 206 controls) who attended a gynecology and obstetrics clinic. PMOS and its phenotypes were determined according to the Rotterdam criteria. Data were collected face-to-face using the Demographic Information Form, anthropometric measurements, and the MIND Diet Adherence Scale. Multivariate logistic regression was used to estimate the relationship between the MIND diet and PMOS and its phenotypes. The significance level was p < 0.05. The median age of the case and control groups was 22.00 years. Phenotype A was the most prevalent in the case group (43.5%). In model 4, which included all confounding factors, it was found that the likelihood of PMOS was significantly lower in the Q4 group who had the highest MIND diet score compared to the Q1 group (AOR:0.166; 95% CI: 0.073-0.378). In terms of phenotypes, the likelihood of having phenotypes A, C, and D was significantly lower in the Q4 group (p < 0.05); however, no statistically significant relationship was found for phenotype B (p > 0.05). This case-control study found that a higher MIND diet score was associated with a lower likelihood of PMOS and of phenotypes A, C, and D.

27 March 2026 in Medicine
Verified
Journal Article
Open access
YBYakup Baykus
Yakup Baykus
RDRulin Deniz
Rulin Deniz
ATAlihan Tığlı
Alihan Tığlı
DADilek Aydin
Dilek Aydin
NŞNazli Şener
Nazli Şener
GAGüzide Ece Akinci
Güzide Ece Akinci
Climate change is increasingly recognized as a major global health threat, disproportionately affecting vulnerable populations such as pregnant women. However, limited research has examined its psychological impacts on this group. This study aimed to examine whether higher climate change awareness is associated with increased symptoms of depression, anxiety, and stress among pregnant women in Türkiye. A cross-sectional study was conducted between April 2025 and June 2025 with 267 pregnant women attending routine obstetric care at a public hospital. Data were collected using a personal information form, the Pregnancy-Specific Climate Change Awareness Scale (PS-CCAS), and the Depression Anxiety Stress Scale. Descriptive statistics, Pearson correlation, and multiple linear regression analyses were used to assess relationships between variables. The mean total PS-CCAS score was 66.81 ± 20.97. Although no significant association was observed with depression, both climate change awareness (PS-CCAS) and climate change knowledge, assessed as a separate variable, emerged as significant predictors of anxiety and stress. Depression was more common among participants with lower education, longer marriage duration, urban residence, and pregnancy-related illness. Anxiety and stress were significantly linked to urban living and pregnancy-related illness, while stress was additionally associated with lower income. These findings highlight the need for targeted, psychologically safe climate education programs during pregnancy. Sociodemographic factors such as education level, income, and urban living should be considered when designing perinatal mental health interventions in the context of climate change.

1 July 2026 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Open access
KDKubra Donmez
Kubra Donmez
YBYakup Baykus
Yakup Baykus
YAYılda Arzu Aba
Yılda Arzu Aba
ATAlihan Tığlı
Alihan Tığlı
RDRulin Deniz
Rulin Deniz
Background and Objectives: This study was conducted to examine the relationship between perceived risk during pregnancy and maternal health literacy, as well as the factors influencing these variables. Materials and Methods: This cross-sectional and correlational study was conducted with 338 pregnant women who attended the Obstetrics and Gynaecology Outpatient Clinic at Bandırma Onyedi Eylül University Hospital between November 2024 and April 2025. Data were collected via face-to-face interviews using the Personal Information Form, the Pregnancy Risk Perception Scale (PRPS) and the Pregnancy Maternal Health Literacy Scale (PMHLS). The Mann-Whitney U and Kruskal-Wallis H tests, as well as Spearman’s correlation analysis, were used to analyse the data. Results: The median total score for the PRPS among pregnant women was 14.3 (Interquartile Range [IQR] = 52.2) and the median total score for the PMHLS was 83.9 (IQR = 42.2). It was observed that pregnant women’s risk perceptions regarding themselves (X̃ = 22.9) were higher than those regarding their babies (X̃ = 10.0). A strong, highly significant negative correlation was found between the two variables (rₛ = −0.86; p < 0.001). Furthermore, it was determined that pregnant women who were university graduates, non-smokers, had taken folic acid before pregnancy and iron supplements during pregnancy, had received a tetanus vaccination, and had attended antenatal classes had higher levels of health literacy and lower levels of risk perception. Conclusion: The findings indicate that higher maternal health literacy is strongly associated with reduced perceived pregnancy-related risks. In this regard, multidisciplinary antenatal education programmes and preventive interventions that enhance health literacy can be utilised as an important clinical strategy to prevent pregnant women from overestimating risks and to facilitate informed risk management.

21 April 2025 in Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi
Verified
Journal Article
Open access
PDF file
ATAlihan Tığlı
Alihan Tığlı
YBYakup Baykus
Yakup Baykus
RDRulin Deniz
Rulin Deniz
NŞNazli Şener
Nazli Şener
GAGüzide Ece Akinci
Güzide Ece Akinci
ASAnil Murat Sever
Anil Murat Sever
Amaç: Toksoplazma gondii, Rubella, Sitomegalovirüs (CMV) gibi enfeksiyöz ajanlar gebelik döneminde intrauterin enfeksiyonlara yol açarak fetal morbidite, mortalite ve anomalilere sebep olabilmektedir. Bu çalışmada Toksoplazma gondii, Rubella, CMV seroprevalanslarının saptanması amaçlanmıştır. Gereç ve Yöntem: Tanımlayıcı retrospektif tipteki araştırmada bir eğitim ve araştırma hastanesi kadın hastalıkları ve doğum polikliniğine 01/01/2017- 01/07/2021 tarihleri arasında gebelik takibi amacıyla başvurarak Toksoplazma gondii, Rubella ve CMV taraması yapılmış olan gebelerin antikor düzeyleri hastane kayıtlarından retrospektif olarak elde edilmiş, yıllara ve yaş gruplarına göre seropravalans değerleri hesaplanmıştır. Bulgular: Bu çalışmada Toksoplasma gondii için 4897, Rubella için 4903 ve CMV için 4600 gebenin test sonuçları değerlendirilmiştir. Sırasıyla Toksoplasma gondii IgM, IgG %1.1, %24.5, Rubella IgM, IgG pozitifliği %0,4, %92.3, CMV IgM, IgG pozitifliği %1.9, %98.6’dır. Toksoplazma IgM(-) saptananların oranı 25-29 yaş grubundaki gebelerde diğer yaş kategorilerine göre yüksektir. 30 yaş ve üzeri gebelerde 25-29 yaş grubuna göre, 25-29 yaş grubu gebelerde 24 yaş ve altındaki gebelere göre Toksoplazma IgG (-) saptananların oranı düşüktür (p0.05). Sonuç: Türkiye’de yapılan çalışmalara göre Toksoplazma IgM (+), IgG (+), Rubella IgG (+) seroprevalansları düşüktür, CMV IgG seropozitifliği ise Türkiye’de yapılan çalışmalara benzerdir. 25-29 yaş grubundaki gebelerde Toksoplazma IgM (-) oranı diğer yaş gruplarına göre yüksektir. Gebelerin yaşının artmasıyla Toksoplazma IgG (-) oranı azalmaktadır. Sitomegalovirüs (CMV) için taramanın cost effektif olmadığı söylenebilir, Toksoplazma gondii ve Rubella için ise taramaların yapılması önerilir.